In this undated photo released by Fujifilm Holdings Corp., anti-influenza tablets fabipiravir are shown. Japan said Monday, Aug. 25, 2014 it is ready to provide a Japanese-developed anti-influenza drug as potential treatment to fight the rapidly expanding Ebola outbreak. The drug, developed by a Fujifilm subsidiary Toyama Chemical Co. to treat novel and re-emerging influenza viruses, was approved by the Japanese health ministry in March. Fujifilm is in talks with the U.S. Food and Drug Administration on clinical testing of the drug in treating Ebola, company spokesman Takao Aoki said. The label reads: fabipiravir. (AP Photo/Fujifilm Holdings Corp.)

In this undated photo released by Fujifilm Holdings Corp., anti-influenza tablets fabipiravir are shown. Japan said Monday, Aug. 25, 2014 it is ready to provide a Japanese-developed anti-influenza drug as potential treatment to fight the rapidly expanding Ebola outbreak. The drug, developed by a Fujifilm subsidiary Toyama Chemical Co. to treat novel and re-emerging influenza viruses, was approved by the Japanese health ministry in March. Fujifilm is in talks with the U.S. Food and Drug Administration on clinical testing of the drug in treating Ebola, company spokesman Takao Aoki said. The Japanese on the tablets reads: AVIGAN, the name used in Japan. (AP Photo/Fujifilm Holdings Corp.)